BE665514A - - Google Patents

Info

Publication number
BE665514A
BE665514A BE665514DA BE665514A BE 665514 A BE665514 A BE 665514A BE 665514D A BE665514D A BE 665514DA BE 665514 A BE665514 A BE 665514A
Authority
BE
Belgium
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of BE665514A publication Critical patent/BE665514A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE665514D 1964-06-16 BE665514A (ko)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL646406797A NL146383B (nl) 1964-06-16 1964-06-16 Werkwijze ter bereiding van anabool werkzame 7alfa-methyl-steroiden van de oestraanreeks, alsmede werkwijze ter bereiding van een farmaceutisch preparaat en gevormd farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
BE665514A true BE665514A (ko)

Family

ID=19790312

Family Applications (1)

Application Number Title Priority Date Filing Date
BE665514D BE665514A (ko) 1964-06-16

Country Status (10)

Country Link
US (1) US3340279A (ko)
BE (1) BE665514A (ko)
BR (1) BR6570429D0 (ko)
CH (1) CH517725A (ko)
DE (1) DE1543273C3 (ko)
DK (1) DK114553B (ko)
FR (1) FR1594513A (ko)
GB (1) GB1104462A (ko)
NL (1) NL146383B (ko)
SE (1) SE336788B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070665A1 (ko) * 1969-09-03 1971-09-17 Upjohn Co

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3875188A (en) * 1968-04-10 1975-04-01 Eugene E Galantay 17-Beta-alpha-lower alkyl allene-substituted steroids
US3997664A (en) * 1971-02-09 1976-12-14 Sandoz, Inc. Substituted carbinol derivatives
US4701450A (en) * 1984-03-21 1987-10-20 Akzo N.V. Steroids for use as immunomodulators
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ES2197677T3 (es) * 1998-10-16 2004-01-01 Akzo Nobel N.V. Composiciones de alta pureza que comprenden (7alfa-17alfa)-17-hidroxi-7-metil-19-nor-17-pregn-5(10)-en-20-in-3-ona.
US20040229854A1 (en) * 2000-11-28 2004-11-18 Pieter Haan De Immediate release dosage form for HRT
GB0304927D0 (en) 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
AU2004203420B8 (en) * 2003-05-23 2008-02-21 N.V. Organon Immediate-release pharmaceutical dosage form comprising polymorphous tibolone
EP1872775A1 (en) * 2006-06-29 2008-01-02 Polichem S.A. Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant for the manufacture of a medicament for treating female genital disorders
EP3452019B1 (en) 2016-05-04 2021-06-23 Novalon S.A. Use of sugar-alcohols in tibolone compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2725389A (en) * 1953-08-31 1955-11-29 Searle & Co 13-methyl-17-ethynyl-17-hydroxy-1, 2, 3, 4, 6, 7, 8, 9, 11, 12, 13, 14, 16, 17-tetradecahydro15h-cyclopenta [a] phenanthren-3-one and its preparation
US3262949A (en) * 1956-11-13 1966-07-26 Syntex Corp 7-methyl androstane compounds
US3086027A (en) * 1960-01-22 1963-04-16 Lilly Co Eli 19-nor-4, 9(10)-steroids and process

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2070665A1 (ko) * 1969-09-03 1971-09-17 Upjohn Co

Also Published As

Publication number Publication date
BR6570429D0 (pt) 1973-08-14
FR1594513A (ko) 1970-06-08
NL146383B (nl) 1975-07-15
CH517725A (de) 1972-01-15
US3340279A (en) 1967-09-05
DE1543273B2 (de) 1973-07-05
NL6406797A (ko) 1965-12-17
DK114553B (da) 1969-07-14
DE1543273A1 (de) 1969-08-07
SE336788B (ko) 1971-07-19
DE1543273C3 (de) 1974-02-21
GB1104462A (en) 1968-02-28

Similar Documents

Publication Publication Date Title
FR1594513A (ko)
BE658887A (ko)
AU442366B2 (ko)
BE642741A (ko)
BE629793A (ko)
BE660122A (ko)
BE660443A (ko)
BE642395A (ko)
BE660052A (ko)
BE660487A (ko)
BE659969A (ko)
BE659477A (ko)
BE660647A (ko)
BE658046A (ko)
BE653975A (ko)
BE652106A (ko)
BE649665A (ko)
BE642654A (ko)
BE642973A (ko)
BE642797A (ko)
BE642770A (ko)
BE642437A (ko)
BE642735A (ko)
BE642589A (ko)
BE642400A (ko)